Status:
COMPLETED
Exhaled Nitric Oxide and Nasal Lavage Fluid
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Asthma
Eligibility:
All Genders
5-16 years
Brief Summary
The allergic respiratory diseases such as asthma or allergic rhinitis are the main chronic diseases in children. The airway inflammation plays an important role in their pathophysiology. Several epide...
Detailed Description
Type of study : This study is a epidemiological observation study type exposed or unexposed to environmental tobacco smoke. Methods : The eNO is determined by a method On-line, at a rate expiratory...
Eligibility Criteria
Inclusion
- Aged over 5 years
- Atopic, persistent mild and moderate Asthmatic Children (GINA 2 and 3)
Exclusion
- Child with asthma medication asthma used in the previous 15 days (oral or inhaled corticosteroids, leukotriene antagonist)
- Recent asthma attack (day of hospitalization or 15 days earlier)
- Upper respiratory infection (4 weeks) and low (2 weeks)
- Active smoking (teenager)
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00773578
Start Date
October 1 2007
End Date
February 1 2009
Last Update
February 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Trousseau
Paris, France, 75020